IDO in Colorectal Tumorigenesis: Involvement of Immune Tolerance and Significance in Prevention and Therapy

Cell Mol Gastroenterol Hepatol. 2021;12(4):1503-1504. doi: 10.1016/j.jcmgh.2021.06.021. Epub 2021 Jul 17.

Authors

Shunan Tang¹, Jingya Wang¹, Siwang Yu²

Affiliations

¹ State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, Peking University School of Pharmaceutical Sciences, Beijing, China.
² State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, Peking University School of Pharmaceutical Sciences, Beijing, China. Electronic address: swang_yu@hsc.pku.edu.cn.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinogenesis
Cell Transformation, Neoplastic
Colorectal Neoplasms* / therapy
Humans
Immune Tolerance*